The table below shows VERTEX PHARMACEUTICALS INC / MA's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$1.43B
$818.90M
$1.31B
$899.90M
$956.20M
$921.00M
Capital expenditure
$133.40M
$40.70M
$68.40M
$42.10M
$63.60M
$70.90M
Investing cash flow
-$431.90M
-$55.80M
-$2.14B
-$1.83B
-$51.00M
-$74.30M
Dividends paid
-
-
-
-
VRTX operating cash flow (10-K history)
VERTEX PHARMACEUTICALS INC / MA reported operating cash flow of $3.63B for fiscal year 2025. That is up 837.2% from -$492.60M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $236.10M (FY 2016) to $3.63B. Figures come from the company's audited annual reports as filed with the SEC.
